We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Light-Activated Nanoparticles Kill Primary Tumors and Distant Metastases

By LabMedica International staff writers
Posted on 27 Sep 2016
Print article
Image: Scientists developed nanoparticles for targeted delivery of chemotherapy. When combined with other cancer treatments, it eradicated tumors in rodents in a recent study (Photo courtesy of Dr. Cecil Fox via Wikimedia Commons).
Image: Scientists developed nanoparticles for targeted delivery of chemotherapy. When combined with other cancer treatments, it eradicated tumors in rodents in a recent study (Photo courtesy of Dr. Cecil Fox via Wikimedia Commons).
A novel type of nanoparticle carries two anticancer drugs to attack colorectal cancer while simultaneously recruiting and activating T-cells to fight the tumors.

Advanced colorectal cancer is one of the deadliest cancers, with a five-year survival rate of only 12% for patients with the metastatic disease. Checkpoint blockade therapy, which counters biochemical signals transmitted by the cancer cells to suppress the immune system and prevent recognition by T-cells, is among the most promising immunotherapies for patients with advanced colon cancer, but has not been particularly successful. This is due in part to the lack of T-cells inside well-established tumors and the difficulty in attracting T-cells from other parts of the body to the tumor.

Investigators at the University of Chicago (IL, USA) have developed a method to enhance the effectiveness of checkpoint blockade therapy. They developed a novel type of nanoparticle assembled from zinc and the drug oxaliplatin, an agent in regular use against advanced-stage metastatic colon cancer. The photosensitizing agent pyrolipid, which attacks tumors following light activation, was used to coat the outer layer of the particles. The nanoparticles therefore represented a method for the effective delivery of both chemotherapy and photodynamic therapy (PDT).

The effectiveness of the particles when tested in a mouse model was as evidenced by early calreticulin (CRT) exposure on the cell surface, antitumor vaccination, tumor-specific T-cell response, and an abscopal effect. The abscopal effect is usually described with ionizing radiation and refers to regression of a tumor outside of the irradiated volume. Although the mechanism is unknown, it is thought to be immune modulated.

The investigators reported in the August 17, 2016, online edition of the journal Nature Communications that in a mouse model nanoparticle treatment in combination with PD-L1 checkpoint blockade, therapy not only led to the regression of the primary tumors treated locally with light irradiation, but also mediated regression of non-irradiated distant tumors by inducing a strong tumor-specific immune response.

“Everybody out there working in the cancer space is trying to figure out ways to enhance checkpoint blockade immunotherapy,” said senior author Dr. Wenbin Lin, professor of chemistry at the University of Chicago. “In this work, we were able to achieve that. We believe that this combination is able to activate the immune system to generate the T-cells that will recognize the cancer cells. Then they go around the body and kill the cancer cells in the distant site that has not been irradiated with the light.”

Related Links:
University of Chicago

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Analyzer 2.0 with remote test results access enhances collaboration across the healthcare system (Photo courtesy of QIAGEN)

Upgraded Syndromic Testing Analyzer Enables Remote Test Results Access

QIAGEN (Venlo, the Netherlands) has released the QIAstat-Dx Analyzer 2.0, including the Software 1.6 upgrade. This represents a significant advancement from the initial QIAstat-Dx Analyzer 1.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The RedDrop One blood collection device has received 510(k) clearance from the U.S. FDA for prescription use (Photo courtesy of RedDrop Dx)

Innovative Blood Collection Device Overcomes Common Obstacles Related to Phlebotomy

The discomfort associated with traditional blood draws leads to a significant issue: approximately 30% of diagnostic tests prescribed by physicians are never completed by patients. This avoidance is often... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.